Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control

Jee Hee Yoo; Jae Hyeon Kim

doi:10.4093/dmj.2021.0256

Articles

Page Path: HOME > Diabetes Metab J > Volume 45(5); 2021 > Article

Corrigendum Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control: Jee Hee Yoo¹, Jae Hyeon Kim²; Diabetes & Metabolism Journal 2021;45(5):795-795.
DOI: https://doi.org/10.4093/dmj.2021.0256
Published online: September 30, 2021

5,454 Views
123 Download
5 Web of Science
5 Crossref
6 Scopus

¹Division of Endocrinology and Metabolism, Department of Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea

²Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

prev next

Full Article

Download PDF

About this article

This corrects the article "Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control" on page 828.

Diabetes & Metabolism Journal 2020;44:828-839. https://doi.org/10.4093/dmj.2020.0257

Fig. 1A of this manuscript has some error. The % next to the text “TAR”, “TBR”, and “TAR” should be changed to mg/dL.

We apologize for any inconvenience that this may have caused.

Fig. 1.

(A) Even in patients with the same glycosylated hemoglobin (HbA1c) or mean glucose, exact glycemic control may vary. For example, some patients can have excellent glycemic control, spending the whole day with glucose levels between 70 and 180 mg/dL; on the other hand, some patients’ glucose levels may range from 50 to 250 mg/dL. (B) Self-monitoring blood glucose (SMBG) cannot fully capture actual glycemic fluctuation like continuous glucose monitoring (CGM) measuring interstitial glucose level every 5 to 15 minutes (96 to 288 measurements/day). TAR, time above range; TBR, time below range; TIR, time in range.

Figure & Data

References

Citations

Citations to this article as recorded by

Dapagliflozin-linagliptin combination improves time-in-range and hepatorenal function in T2DM with hypertension
Wenxia Li, Chaoqin Chen, Shanshan Li, Jianguang Ren
Asian Journal of Surgery.2026; 49(1): 347. CrossRef
Glycemia Risk Index is Associated With Risk of Albuminuria Among Individuals With Type 1 Diabetes
Ji Yoon Kim, Jee Hee Yoo, Nam Hoon Kim, Jae Hyeon Kim
Journal of Diabetes Science and Technology.2025;[Epub] CrossRef
Association between continuous glucose monitoring metrics and cardiovascular autonomic neuropathy in diabetic patients: a systematic review
Yifan Jia, Dan Long, Wei Song, Qiong Wang, Qian Zhang
Reviews in Endocrine and Metabolic Disorders.2025; 26(6): 973. CrossRef
Association of circulating 25-hydroxyvitamin D with time in range and insulin secretion in type 2 diabetes
Wenwen Jiang, Ling Li, Wei Wang, Yue Liang, Xiaoyong Bai, Yixin Xu, Qingyu Guo, Lichao Ge, Jingjing Liang, Bin Lu, Jiaqing Shao
Frontiers in Endocrinology.2025;[Epub] CrossRef
Association Between Serum Uric Acid to Creatinine Ratio and Time in Range in Patients With Type 2 Diabetes
Yu Gong, Ying Li, Qianqian Zhang, Zhangxiang Zhu, Guojuan Wang
Clinical Endocrinology.2025; 103(5): 682. CrossRef

PubReader
ePub Link

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control

Diabetes Metab J. 2021;45(5):795-795. Published online September 30, 2021

DOI: https://doi.org/10.4093/dmj.2021.0256

XML Download

Figure

Related articles

Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control

Fig. 1. (A) Even in patients with the same glycosylated hemoglobin (HbA1c) or mean glucose, exact glycemic control may vary. For example, some patients can have excellent glycemic control, spending the whole day with glucose levels between 70 and 180 mg/dL; on the other hand, some patients’ glucose levels may range from 50 to 250 mg/dL. (B) Self-monitoring blood glucose (SMBG) cannot fully capture actual glycemic fluctuation like continuous glucose monitoring (CGM) measuring interstitial glucose level every 5 to 15 minutes (96 to 288 measurements/day). TAR, time above range; TBR, time below range; TIR, time in range.

Fig. 1.

Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control

About this article

Yoo JH, Kim JH. Time in Range from Continuous Glucose Monitoring: A Novel Metric for Glycemic Control. Diabetes Metab J. 2021;45(5):795-795.

DOI: https://doi.org/10.4093/dmj.2021.0256.

Download citation ↓